{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:50:56Z","timestamp":1792759856867,"version":"4.5.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Invasive tracheobronchial aspergillosis (ITBA) is an uncommon but severe clinical form of invasive pulmonary aspergillosis in which the fungal infection is entirely or predominantly confined to the tracheobronchial tree.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To analyze the diagnostic and prognostic differences between tracheobronchial aspergillosis and pulmonary aspergillosis without tracheobronchial lesions among patients admitted to the ICU with severe influenza.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective, observational study included critically ill patients with influenza associated with pulmonary aspergillosis from three hospital ICUs between 2010 and 2019. Patient characteristics and clinical and mycologic data at admission and during ICU stay were collected in a database to evaluate variables in the two groups.<\/jats:p>\n                    <jats:p>Measurements and Main Results: Thirty-five patients admitted to the ICU with severe influenza and pulmonary aspergillosis were included. Ten patients were included in the group with ITBA (n\u2009=\u200910 of 35; 28.6%), and 25 patients were included in the group without ITBA. The group with ITBA comprised more patients with active smoking, diabetes mellitus, and higher severity scores (Simplified Acute Physiology Score II). Ninety-day mortality rates in the groups with and without ITBA were 90% and 44%, respectively (P\u2009=\u20090.02). Moreover, significantly higher serum 1,3-\u03b2-d \u00a0-glucan and galactomannan and BAL fluid galactomannan concentrations were observed in the group with ITBA compared with the group without ITBA (P\u2009&amp;lt;\u20090.0001, P\u2009=\u20090.003, and P\u2009=\u20090.008, respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>ITBA was associated with higher severity scores, mortality, and serum and BAL fluid galactomannan and 1,3-\u03b2-d-glucan concentrations than invasive pulmonary aspergillosis without tracheobronchial lesions. ITBA should be systematically researched by bronchoscopic examination in ICU patients with concomitant pulmonary aspergillosis and influenza.<\/jats:p>\n                    <jats:p>Clinical trial registered with www.clinicaltrials.gov (NCT 04077697).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.201910-1931oc","type":"journal-article","created":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T15:43:30Z","timestamp":1589471010000},"page":"708-716","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":65,"title":["Invasive Tracheobronchial Aspergillosis in Critically Ill Patients with Severe Influenza. A Clinical Trial"],"prefix":"10.1093","volume":"202","author":[{"given":"Remy","family":"Nyga","sequence":"first","affiliation":[{"name":"Department of Medical Intensive Care"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Maizel","sequence":"additional","affiliation":[{"name":"Department of Medical Intensive Care"},{"name":"MP3CV-EA 7517"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Nseir","sequence":"additional","affiliation":[{"name":"Intensive Resuscitation Medicine Unit, Lille University Hospital Center"},{"name":"Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taieb","family":"Chouaki","sequence":"additional","affiliation":[{"name":"Department of Medical Parasitology and Mycology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivona","family":"Milic","sequence":"additional","affiliation":[{"name":"Department of Medical Intensive Care"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Alexandre","family":"Roger","sequence":"additional","affiliation":[{"name":"Department of Respiratory Intensive Care"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Van Grunderbeeck","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Schaffner Hospital, Lens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Lemyze","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Schaffner Hospital, Lens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Totet","sequence":"additional","affiliation":[{"name":"Department of Medical Parasitology and Mycology"},{"name":"UR UPJV 4294, Infectious Agents, Resistance and Chemotherapy Research Unit, University Center for Health Research, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Castelain","sequence":"additional","affiliation":[{"name":"UR UPJV 4294, Infectious Agents, Resistance and Chemotherapy Research Unit, University Center for Health Research, and"},{"name":"Department of Virology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Slama","sequence":"additional","affiliation":[{"name":"Department of Medical Intensive Care"},{"name":"MP3CV-EA 7517"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Dupont","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care Medicine, Amiens University Hospital, Amiens, France"},{"name":"Simplification of Complex Surgical Patient Care BQR Unit of Clinical Research, Picardy Jules Verne University, Amiens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boualem","family":"Sendid","sequence":"additional","affiliation":[{"name":"Laboratory of Medical Parasitology and Mycology, Regional University Hospital Center, and"},{"name":"Fungally Associated Invasive and Inflammatory Diseases Team, National Institute of Health and Medical Research U995\u2013Lille Inflammation Research International Center, Lille University, Lille, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Zogheib","sequence":"additional","affiliation":[{"name":"Department of Medical Intensive Care"},{"name":"MP3CV-EA 7517"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,9,1]]},"reference":[{"key":"2026030321485043000_bib1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2026030321485043000_bib2","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1164\/rccm.200401-093OC","article-title":"Invasive aspergillosis in critically ill patients without malignancy","volume":"170","author":"Meersseman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321485043000_bib3","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1469-0691.2009.03015.x","article-title":"Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome","volume":"16","author":"Guinea","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"2026030321485043000_bib4","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2026030321485043000_bib5","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1164\/rccm.201612-2540LE","article-title":"Influenza-associated aspergillosis in critically ill patients","volume":"196","author":"Van de Veerdonk","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321485043000_bib6","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/clinids\/17.3.344","article-title":"Ulcerative and plaque-like tracheobronchitis due to infection with Aspergillus in patients with AIDS","volume":"17","author":"Kemper","year":"1993","journal-title":"Clin Infect Dis"},{"key":"2026030321485043000_bib7","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1164\/ajrccm\/144.3_Pt_1.552","article-title":"Ulcerative tracheobronchitis after lung transplantation: a new form of invasive aspergillosis","volume":"144","author":"Kramer","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"2026030321485043000_bib8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/MD.0b013e31826c2ccf","article-title":"Aspergillus tracheobronchitis: report of 8 cases and review of the literature","volume":"91","author":"Fern\u00e1ndez-Ruiz","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"2026030321485043000_bib9","doi-asserted-by":"crossref","first-page":"ofw171","DOI":"10.1093\/ofid\/ofw171","article-title":"Invasive aspergillosis associated with severe influenza infections","volume":"3","author":"Crum-Cianflone","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"2026030321485043000_bib10","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1007\/s00134-016-4379-3","article-title":"Severe ARDS in a critically ill influenza patient with invasive pulmonary aspergillosis","volume":"42","author":"Pietsch","year":"2016","journal-title":"Intensive Care Med"},{"key":"2026030321485043000_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3947\/ic.2014.46.3.209","article-title":"Aspergillus tracheobronchitis and influenza A Co-infection in a patient with AIDS and neutropenia","volume":"46","author":"Lee","year":"2014","journal-title":"Infect Chemother"},{"key":"2026030321485043000_bib12","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2026030321485043000_bib13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","article-title":"A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients","volume":"186","author":"Blot","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321485043000_bib14","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"2026030321485043000_bib15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/cid\/ciz391","article-title":"Influenza coinfection: be(a)ware of invasive aspergillosis","volume":"70","author":"Verweij","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2026030321485043000_bib16","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1186\/cc9402","article-title":"Clinical features of invasive bronchial-pulmonary aspergillosis in critically ill patients with chronic obstructive respiratory diseases: a prospective study","volume":"15","author":"He","year":"2011","journal-title":"Crit Care"},{"key":"2026030321485043000_bib17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/myc.12185","article-title":"Aspergillus tracheobronchitis in critically ill patients with chronic obstructive pulmonary diseases","volume":"57","author":"He","year":"2014","journal-title":"Mycoses"},{"key":"2026030321485043000_bib18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1586\/17476348.2015.996132","article-title":"Invasive pulmonary aspergillosis in patients with influenza infection: report of two cases and systematic review of the literature","volume":"9","author":"Alshabani","year":"2015","journal-title":"Expert Rev Respir Med"},{"key":"2026030321485043000_bib19","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1093\/cid\/cir485","article-title":"Invasive aspergillosis complicating pandemic influenza A (H1N1) infection in severely immunocompromised patients","volume":"53","author":"Garcia-Vidal","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2026030321485043000_bib20","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1469-0691.2009.02923.x","article-title":"Isolated invasive Aspergillus tracheobronchitis: a clinical study of 19 cases","volume":"16","author":"Wu","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"2026030321485043000_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1439-0507.2005.01180.x","article-title":"Pseudomembranous and obstructive Aspergillus tracheobronchitis - optimal diagnostic strategy and outcome","volume":"49","author":"Tasci","year":"2006","journal-title":"Mycoses"},{"key":"2026030321485043000_bib22","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/503427","article-title":"Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis","volume":"42","author":"Pfeiffer","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2026030321485043000_bib23","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1164\/rccm.201903-0587LE","article-title":"Detection of invasive aspergillosis in critically ill patients with influenza: the role of plasma galactomannan","volume":"200","author":"van de Groep","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321485043000_bib24","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1128\/JCM.00345-17","article-title":"Diagnostic value of galactomannan antigen test in serum and bronchoalveolar lavage fluid samples from patients with nonneutropenic invasive pulmonary aspergillosis","volume":"55","author":"Zhou","year":"2017","journal-title":"J Clin Microbiol"},{"key":"2026030321485043000_bib25","doi-asserted-by":"crossref","first-page":"R138","DOI":"10.1186\/cc11443","article-title":"Role of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: a prospective study","volume":"16","author":"He","year":"2012","journal-title":"Crit Care"},{"key":"2026030321485043000_bib26","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/myc.12221","article-title":"Serum 1,3-beta-d-glucan for antifungal treatment stratification at the intensive care unit and the influence of surgery","volume":"57","author":"Prattes","year":"2014","journal-title":"Mycoses"},{"key":"2026030321485043000_bib27","doi-asserted-by":"crossref","first-page":"21484","DOI":"10.18632\/oncotarget.7471","article-title":"(1, 3)-\u03b2-d-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies","volume":"7","author":"Azoulay","year":"2016","journal-title":"Oncotarget"},{"key":"2026030321485043000_bib28","doi-asserted-by":"crossref","first-page":"e0129022","DOI":"10.1371\/journal.pone.0129022","article-title":"Correlation between circulating fungal biomarkers and clinical outcome in invasive aspergillosis","volume":"10","author":"Neofytos","year":"2015","journal-title":"PLoS One"},{"key":"2026030321485043000_bib29","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1086\/528714","article-title":"Strong correlation between serum aspergillus galactomannan index and outcome of aspergillosis in patients with hematological cancer: clinical and research implications","volume":"46","author":"Miceli","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2026030321485043000_bib30","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/505870","article-title":"Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey","volume":"43","author":"Cornillet","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2026030321485043000_bib31","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jinf.2012.07.007","article-title":"A strategy based on galactomannan antigen detection and PCR for invasive pulmonary aspergillosis following influenza A (H1N1) pneumonia","volume":"65","author":"Guervilly","year":"2012","journal-title":"J Infect"},{"key":"2026030321485043000_bib32","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1086\/586739","article-title":"Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial","volume":"46","author":"Rijnders","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2026030321485043000_bib33","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s00134-012-2673-2","article-title":"Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study","volume":"38","author":"Wauters","year":"2012","journal-title":"Intensive Care Med"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/202\/5\/708\/67176680\/ajrccm_202_5_708.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/202\/5\/708\/67176680\/ajrccm_202_5_708.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T02:49:01Z","timestamp":1772592541000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/202\/5\/708\/8495360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,9,1]]},"published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201910-1931oc","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,9]]},"published":{"date-parts":[[2020,9,1]]},"assertion":[{"value":"2019-10-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}